Bo Kreilgaard

Bo Kreilgaard
Ph.D.Pharm., Senior Regulatory Affairs Manager

Bo Kreilgaard holds a Ph.D. and a M.Sc. Pharmacy from the former Royal Danish School of Pharmacy. He has been with Billev Pharma since February 2016 and now holds the position as Senior Regulatory Affairs Manager.

  • 20 years of experience within analytical research and pharmaceutical development at Pharmacia&Upjohn as well as 12 years’ experience within QC (including Qualified Person) and project management at a Global Danish Pharmaceutical Company
  •  Former member of the Danish Pharmacopoeial Commission (Chemistry)
  • Former speaker at postgraduate courses for pharmacists (module 3, specifications, stability).
 
Services

Registration

We are well-equipped to provide regulatory advice, discuss strategy and/or compile the registration dossier. 

Pharmacovigilance

We have a team of highly qualified pharmacovigilance employees with expertise in all aspects of pharmacovigilance.

Translations

We offer high quality medical & pharmaceutical translations into and from several European languages.

Electronic submission

We are equipped to assist with any type of electronic submission and maintenance of your electronic file.

Special medicines areas

Herbal medicinal products, strong vitamin and mineral products, medicinal gasses, euphoriant substances, etc.

GDP & GMP Services

We offer full time and part time responsible person (RP) function and qualified person (QP) function.

Latest News

Simple solutions in a complex PV environment

We are happily handling an increasing number of pharmacovigilance responsibilities for our clients in a complex pharmacovigilance environment. Our team of pharmacovigilance experts is now organised in three different fields – Human Accounts, Veterinary Accounts, and...

Dyrlæger i life science

I det nyeste nummer af Pharma kan du læse om vores kollega Charlotte Lindorf Eriksen og hendes arbejde med pharmacovigilance som dyrlæge i Billev Pharma Pharma nr. 3 2023—Side 14 (ipaper.io). Charlotte er netop blevet forfremmet til Head of Pharmacovigilance og har...